Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation
Open Access
- 14 July 2022
- journal article
- review article
- Published by Frontiers Media SA in Advances in Drug and Alcohol Research
- Vol. 2
Abstract
Cannabinoids and the endocannabinoid system have been well established to play a crucial role in the regulation of the immune response. Also, emerging data from numerous investigations unravel the imperative role of gut microbiota and their metabolites in the maintenance of immune homeostasis and gut barrier integrity. In this review, we concisely report the immunosuppressive mechanisms triggered by cannabinoids, and how they are closely associated with the alterations in the gut microbiome and metabolome following exposure to endogenous or exogenous cannabinoids. We discuss how cannabinoid-mediated induction of microbial secondary bile acids, short chain fatty acids, and indole metabolites, produced in the gut, can suppress inflammation even in distal organs. While clearly, more clinical studies are necessary to establish the cross talk between exo- or endocannabinoid system with the gut microbiome and the immune system, the current evidence opens a new avenue of cannabinoid-gut-microbiota-based therapeutics to regulate immunological disorders.Keywords
Funding Information
- Office of Extramural Research
This publication has 105 references indexed in Scilit:
- Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer DiseasePLOS ONE, 2012
- The Role of the PI3K Signaling Pathway in CD4+ T Cell Differentiation and FunctionFrontiers in Immunology, 2012
- Molecular Mechanisms of Treg-Mediated T Cell SuppressionFrontiers in Immunology, 2012
- Butyrate Enhances Disease Resistance of Chickens by Inducing Antimicrobial Host Defense Peptide Gene ExpressionPLOS ONE, 2011
- Cannabinoid receptor activation leads to massive mobilization of myeloid‐derived suppressor cells with potent immunosuppressive propertiesEuropean Journal of Immunology, 2010
- The endocannabinoid system links gut microbiota to adipogenesisMolecular Systems Biology, 2010
- Cannabinoids as Novel Anti-Inflammatory DrugsFuture Medicinal Chemistry, 2009
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: Potential role for CB2-selective ligands as immunosuppressive agentsClinical Immunology, 2007
- Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibioticProceedings of the National Academy of Sciences, 2006